Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities
JCO Oncology Practice · 2024
DOI: 10.1200/op.24.00081 ↗Kurz gefasst
Editorial in der Zeitschrift JCO Oncology Practice, 2024. Verfasst von Mazie Tsang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic, Phoenix, AZ. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Terminal Care, Palliative Care. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Themen: Palliativpflege
Abstract (Originalsprache)
@JCOOP_ASCO editorial on unique needs of end-of-life care for different blood cancers discusses: #pallheme improves QOL but less utilized in cancers. Contextualize Weisse et al study. More #pallheme research needed for lymphoma and myeloma in era of cell therapy
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Mayo Clinic, Phoenix, AZ.
- Duke Cancer Institute, Durham, NC.
ORCID-Profile: Mazie Tsang, Thomas W LeBlanc
Zitieren
APA
Tsang, M., & LeBlanc, T. W. (2024). Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities. JCO Oncology Practice. https://doi.org/10.1200/op.24.00081
Vancouver
Tsang M, LeBlanc TW. Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities. JCO Oncology Practice. 2024. doi:10.1200/op.24.00081
BibTeX
@article{Tsang2024,
author = {Tsang, Mazie and LeBlanc, Thomas W},
title = {Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities},
journal = {JCO Oncology Practice},
year = {2024},
doi = {10.1200/op.24.00081}
}
EUVIMED